SMH

Kosmos Energy Announces First Quarter 2024 Results

Retrieved on: 
Tuesday, May 7, 2024
Other Energy, Oil, Gas, Natural Resources, Energy, Maritime, Logistics, Supply Chain Management, Transport, Mining, Minerals, Tiberius, FPSO, FLNG, Barrel, Partnership, Webcast, Water, Public expenditure, SMH, ILX, Odd job, Hook-up, Growth, RBL, Government

Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for the first quarter of 2024.

Key Points: 
  • Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for the first quarter of 2024.
  • Kosmos exited the first quarter of 2024 with approximately $2.7 billion of total long-term debt and approximately $2.4 billion of net debt(1) and available liquidity of approximately $954 million.
  • Hookup and commissioning of the FPSO remain on the critical path to first gas, expected in the third quarter of 2024 with first LNG expected in the fourth quarter of 2024.
  • Kosmos will host a conference call and webcast to discuss first quarter 2024 financial and operating results today, May 7, 2024, at 10:00 a.m. Central time (11:00 a.m. Eastern time).

Quintus Hot Isostatic Press Tops Off End-to-End AM Capabilities for Australia's Sydney Manufacturing Hub

Retrieved on: 
Tuesday, April 16, 2024
University, HIP, University of Sydney, Hub, SME, Ductility, Research, Workflow, 3D, High, SMH, Science, Fatigue, Quintus, Mining, Ageing, Temperature, Powder metallurgy

VÄSTERÅS, Sweden, April 15, 2024 /PRNewswire-PRWeb/ -- A Hot Isostatic Press from Quintus Technologies will add a new capability to the world-leading research infrastructure already in place at the Sydney Manufacturing Hub (SMH), the advanced manufacturing research facility at the University of Sydney, Australia.

Key Points: 
  • VÄSTERÅS, Sweden, April 15, 2024 /PRNewswire-PRWeb/ -- A Hot Isostatic Press from Quintus Technologies will add a new capability to the world-leading research infrastructure already in place at the Sydney Manufacturing Hub (SMH), the advanced manufacturing research facility at the University of Sydney, Australia.
  • "This hot isostatic press delivers enormous uplift in our university's contribution to the national advanced manufacturing capability," states Prof. Ringer.
  • "It aligns critically with our own initiatives such as at the Sydney Biomedical Accelerator and our Net Zero Initiative.
  • It will be installed in the Hub's purpose-built facility on the University of Sydney's Darlington campus in January 2025.

SARASOTA MEMORIAL HEALTHCARE FOUNDATION MAKES HISTORY RAISING OVER $93 MILLION FOR CANCER CARE AT SMH

Retrieved on: 
Monday, April 15, 2024
Education, Cancer, Brachytherapy, Patient, Research, Surgical oncology, SMH, Family, Multimedia, Rehabilitation, Radiation, Growth, Hospital

SARASOTA, Fla., April 15, 2024 /PRNewswire/ -- Sarasota Memorial Healthcare Foundation announced today that its Leading with Care cancer campaign raised over $93 million to support the Brian D. Jellison Cancer Institute at Sarasota Memorial Health Care System (SMH).

Key Points: 
  • SARASOTA, Fla., April 15, 2024 /PRNewswire/ -- Sarasota Memorial Healthcare Foundation announced today that its Leading with Care cancer campaign raised over $93 million to support the Brian D. Jellison Cancer Institute at Sarasota Memorial Health Care System (SMH).
  • The $93-plus million campaign is the largest in Sarasota Memorial Healthcare Foundation's 48-year history.
  • SMH's vision to transform cancer care was born nearly 10 years ago in response to the southwest Florida community's rapid growth and increase in cancer cases.
  • As SMH's philanthropic arm, the Healthcare Foundation launched its cancer fundraising campaign in 2017 with a goal to raise $50 million in five years.

$25M Gift Spurs Transformative Research, Innovative Learning Environment at Sarasota, Fla. Hospital Campus

Retrieved on: 
Thursday, December 7, 2023
Sarasota Memorial Hospital, Research, Education, Nursing, Love, Student, Patient, Suncoast, COVID-19, Rachel Verinder, Gastroenterology, MD, Cancer, Physician, SMH, Life, Family, Pharmaceutical industry

Family's $25M Gift Spurs Transformative Research, Innovative Learning Environment at Sarasota, Fla. Hospital Campus.

Key Points: 
  • Family's $25M Gift Spurs Transformative Research, Innovative Learning Environment at Sarasota, Fla. Hospital Campus.
  • The Kolschowskys' support has already led to transformative changes that have elevated the quality of care in this community for generations to come, said Sarasota Memorial CEO David Verinder.
  • By lending their name to the building, the Kolschowskys hope to inspire other philanthropists to fund community hospital research initiatives and clinical advances.
  • "The whole community benefits from the transformation taking place in our health system," Sarasota Memorial Healthcare Foundation President Stacey Corley said.

Forbes Names SMH Among America's Best-in-State Employers

Retrieved on: 
Wednesday, August 23, 2023
Magnet, Sarasota Memorial Hospital, Rachel Verinder, Partnership, SMH, Centers for Medicare & Medicaid Services, Hospital, Microsoft, U.S. News & World Report, Medicare, NASA, Statista, News, Pharmaceutical industry, Management, Newsweek, Costco, Suncoast

SARASOTA, Fla., Aug. 23, 2023 /PRNewswire/ -- Sarasota Memorial Health Care System (SMH) has been named in Forbes' fifth annual list of America's "Best-in-State" employers.

Key Points: 
  • SARASOTA, Fla., Aug. 23, 2023 /PRNewswire/ -- Sarasota Memorial Health Care System (SMH) has been named in Forbes' fifth annual list of America's "Best-in-State" employers.
  • On Tuesday, Forbes published its list of 1,392 Best-in-State Employers.
  • Of 90 companies listed in Florida, SMH ranks #4, sharing the top tier with NASA, Google, Microsoft and Costco.
  • Forbes and Statista Inc. Best-in-State Employers list was announced on Aug. 22, 2023, and can currently be viewed on the Forbes website at https://www.forbes.com/lists/best-employers-by-state/?sh=6408cfc01983

Gilbane Building Company and Sarasota Memorial Health Care System, Celebrate the Topping Out of the Venice Campus Bed Tower Expansion

Retrieved on: 
Friday, April 28, 2023
ENR, SMH, Bed, Health care, Gilbane Building Company, Growth, Sarasota Memorial Hospital, Hospital

Venice, Fla., April 28, 2023  /PRNewswire-PRWeb/ -- Gilbane Building and Sarasota Memorial Health Care System marked a major milestone with the topping out of the Venice Campus Bed Tower expansion. Opening in 2024, the new patient tower will add 102 new private patient rooms to the Venice hospital, with dedicated surgical, cardiac, and orthopedic units and expanded space for clinical and support departments.

Key Points: 
  • Venice, Fla., April 28, 2023 /PRNewswire-PRWeb/ -- Gilbane Building and Sarasota Memorial Health Care System marked a major milestone with the topping out of the Venice Campus Bed Tower expansion.
  • Meanwhile, Sarasota Memorial is also moving forward with expanding the Venice Hospital's Emergency Care Center and surgical division to double capacity in those areas.
  • "These are critical expansions that will improve access and care for the entire region," said Sarasota Memorial CEO David Verinder.
  • The SMH Venice project has won numerous design awards and a recent Construction Award of Merit for "Best Projects" from ENR magazine.

Globex Optionee Maple Gold Reports Assay Results at Eagle Mine

Retrieved on: 
Thursday, April 6, 2023
MGM, SMH, GMX, FSE, Geo, See, NMH, Gold, NI, Toronto Stock Exchange, Maple, Palladium, Gum arabic, Nightclub, Eagle, Chicago Mercantile Exchange

The results continue to demonstrate continuity of mineralization and the potential significance of the multiple horizons/splays to the northwest of the former Eagle mine.

Key Points: 
  • The results continue to demonstrate continuity of mineralization and the potential significance of the multiple horizons/splays to the northwest of the former Eagle mine.
  • EM-22-008W intersected 6.2 grams per tonne ("g/t") gold ("Au") over 2.0 m in the South Mine Horizon ("SMH") and 4.2 g/t Au over 3.9 m in sediments further downhole.
  • EM-22-006W4 intersected 4.0 g/t Au over 0.7 m within a broader 1.1 g/t Au over 14.2 m intercept within the SMH.
  • at 6.5 g/t Au from 1974 – 1993, during a period when the price of gold averaged approximately $350 per ounce.

Sanders Morris Harris and Proteus, LLC Renew Partnership Goals to Expand Private Investment Opportunities to RIAs and Fund Managers

Retrieved on: 
Thursday, April 6, 2023
RIA, Cultural Institutions Group, Proteus, Partnership, Accredited investor, SMH, Investment, GP, Financial adviser

INDIANAPOLIS, April 6, 2023 /PRNewswire/ -- Proteus, LLC, an innovative portfolio management and private investment solutions provider, and Sanders Morris Harris (SMH), a high-touch custodial and brokerage service provider, have renewed their partnership commitment to bring a full-service, private investment solution to RIA clients.

Key Points: 
  • INDIANAPOLIS, April 6, 2023 /PRNewswire/ -- Proteus, LLC, an innovative portfolio management and private investment solutions provider, and Sanders Morris Harris (SMH), a high-touch custodial and brokerage service provider, have renewed their partnership commitment to bring a full-service, private investment solution to RIA clients.
  • "Sanders Morris Harris was an early adopter of the Proteus Platform and was instrumental in helping us establish relationships with Dallas area GPs residing on our platform.
  • We look forward to growing our partnership to continue meeting the private investment needs of their client base."
  • SMH provides custodial services to advisors and will continue to use Proteus, LLC as an alternative investment platform through their Institutional Group.

Sarasota Memorial Hospital (Fla) Named Among "World's Best Hospitals"

Retrieved on: 
Thursday, March 2, 2023
Statista, Research, Ageing, Sarasota Memorial Hospital, SMH, Patient, Health, Nursing, Medicine, Hospital, Physician, Newsweek

SARASOTA, Fla., March 2, 2023 /PRNewswire/ -- Sarasota Memorial Hospital was recognized among the world's best hospitals Wednesday in Newsweek and Statista Inc.'s fifth annual global ranking of hospitals.

Key Points: 
  • SARASOTA, Fla., March 2, 2023 /PRNewswire/ -- Sarasota Memorial Hospital was recognized among the world's best hospitals Wednesday in Newsweek and Statista Inc.'s fifth annual global ranking of hospitals.
  • The Sarasota (FL) hospital has made the World's Best Hospitals list each year since the global rankings began in 2018.
  • The world's best hospitals consistently attract the best people and provide the best outcomes for patients as well as the most important new therapies and research."
  • The 2023 World Best Hospital rankings are published online at: https://www.newsweek.com/rankings/worlds-best-hospitals-2023

Olatec Therapeutics Announces the Final Closing, Led by Sanders Morris Harris, on Its $40 Million Series A Financing Round

Retrieved on: 
Thursday, February 23, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Risk management, Therapy, NLRP3, Executive Committee, University, Policy, Army School of Logistics, S-1 Executive Committee, Texas Southern University, Aviation medicine, Drug development, Public, Marsh, Patient, SMH, Growth, Human services, Office of Inspector General, U.S. Department of Health and Human Services, Pharmacy, HR, Advection, Pharmaceutical industry, Cryptocurrency, Northwestern University

Olatec Therapeutics LLC (“Olatec” or the “Company”), a leader in developing NLRP3 inhibitors, announced the completion of the Company’s $40 million Series A round financing, the final closing of which was led by Sanders Morris Harris (“SMH”).

Key Points: 
  • Olatec Therapeutics LLC (“Olatec” or the “Company”), a leader in developing NLRP3 inhibitors, announced the completion of the Company’s $40 million Series A round financing, the final closing of which was led by Sanders Morris Harris (“SMH”).
  • Participation in the round came from both existing investors as well as new investors identified by each of Sanders Morris Harris, Advection Growth Capital and the Company.
  • Proceeds will be principally used to advance Olatec’s lead compound, dapansutrile, into later stage clinical development.
  • Upon completion of its ongoing trials, the Company could be poised for even greater value creation.